Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,141 | 657 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,525 | 203 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $837.61 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $658.33 | 36 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $612.32 | 29 | $0 (2024) |
| QOL Medical, LLC | $567.10 | 31 | $0 (2024) |
| Daiichi Sankyo Inc. | $525.95 | 26 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $514.42 | 33 | $0 (2024) |
| Celgene Corporation | $479.05 | 47 | $0 (2024) |
| Allergan Inc. | $351.35 | 17 | $0 (2018) |
| Merck Sharp & Dohme LLC | $341.89 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,756 | 102 | ABBVIE INC. ($430.26) |
| 2023 | $1,784 | 117 | ABBVIE INC. ($403.98) |
| 2022 | $1,935 | 137 | ABBVIE INC. ($564.97) |
| 2021 | $1,418 | 100 | AbbVie Inc. ($286.38) |
| 2020 | $409.32 | 26 | AbbVie Inc. ($157.93) |
| 2019 | $1,442 | 98 | AbbVie, Inc. ($337.36) |
| 2018 | $1,078 | 65 | AbbVie, Inc. ($264.98) |
| 2017 | $317.81 | 12 | Allergan Inc. ($166.41) |
All Payment Transactions
657 individual payment records from CMS Open Payments — Page 25 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Immunology | ||||||
| 09/13/2018 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Allergy/Immunology | ||||||
| 09/10/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Immunology | ||||||
| 09/06/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Gastroenterology | ||||||
| 09/05/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $12.80 | General |
| 08/29/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Lower GI | ||||||
| 08/24/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Immunology | ||||||
| 08/23/2018 | Echosens North America, Inc. | Fibroscan (Device) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Elastography | ||||||
| 08/17/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Anemia | ||||||
| 08/14/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Immunology | ||||||
| 08/09/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Gastroenterology | ||||||
| 08/06/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Endocrinology | ||||||
| 07/27/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Immunology | ||||||
| 07/25/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/19/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $85.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $54.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Lower GI | ||||||
| 07/10/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2018 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 06/27/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Immunology | ||||||
| 06/27/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/15/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/15/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 677 | 716 | $744,089 | $215,676 |
| 2022 | 13 | 717 | 760 | $617,638 | $180,492 |
| 2021 | 13 | 736 | 791 | $553,346 | $169,801 |
| 2020 | 16 | 705 | 758 | $552,132 | $154,744 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 190 | 190 | $237,500 | $71,648 | 30.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2023 | 52 | 57 | $131,100 | $48,588 | 37.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 80 | 80 | $92,000 | $26,988 | 29.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 86 | 88 | $96,800 | $17,720 | 18.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 41 | 41 | $47,150 | $14,018 | 29.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 36 | 36 | $41,400 | $8,705 | 21.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 38 | 38 | $19,158 | $7,478 | 39.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 16 | 36 | $20,400 | $7,388 | 36.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 18 | 18 | $20,700 | $3,753 | 18.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $18,611 | $2,379 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 29 | $3,480 | $1,745 | 50.1% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 17 | 26 | $4,550 | $1,697 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $2,625 | $1,324 | 50.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $2,856 | $1,156 | 40.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 13 | 13 | $5,759 | $1,088 | 18.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 161 | 162 | $202,500 | $60,336 | 29.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2022 | 32 | 36 | $82,800 | $33,628 | 40.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 65 | 65 | $71,500 | $13,682 | 19.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 30 | 30 | $34,500 | $10,688 | 31.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 29 | 29 | $33,350 | $9,978 | 29.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 46 | 46 | $52,900 | $9,787 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 90 | $15,750 | $8,073 | 51.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 35 | 35 | $16,940 | $6,942 | 41.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 14 | 25 | $15,625 | $5,701 | 36.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 18 | 18 | $20,700 | $4,892 | 23.6% |
About Dr. Patrick Kenny, DO
Dr. Patrick Kenny, DO is a Internal Medicine healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174509491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Kenny, DO has received a total of $10,141 in payments from pharmaceutical and medical device companies, with $1,756 received in 2024. These payments were reported across 657 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,141).
As a Medicare-enrolled provider, Kenny has provided services to 2,835 Medicare beneficiaries, totaling 3,025 services with total Medicare billing of $720,712. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Lynchburg, VA
- Active Since 12/19/2005
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174509491
Products in Payments
- ZEPOSIA (Drug) $664.03
- Linzess (Drug) $612.32
- RINVOQ (Biological) $553.58
- INJECTAFER (Drug) $525.95
- XIFAXAN (Drug) $469.99
- ENTYVIO (Biological) $442.50
- VIBERZI (Drug) $427.34
- SUCRAID (Drug) $390.51
- HUMIRA (Biological) $389.12
- Humira (Biological) $386.16
- DIFICID (Drug) $314.37
- DUPIXENT (Biological) $299.73
- CREON (Drug) $292.53
- LINZESS (Drug) $276.16
- XELJANZ (Drug) $256.41
- STELARA (Biological) $248.11
- SKYRIZI (Biological) $246.79
- TREMFYA (Drug) $240.79
- Cimzia (Drug) $238.01
- ZENPEP (Drug) $214.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lynchburg
Dr. Julia Mchugh, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $31,277
Juan Aponte, Md, MD
Internal Medicine — Payments: $9,659
Richard Miller, Md, MD
Internal Medicine — Payments: $8,691
Dr. Kenneth Musana, Md, MD
Internal Medicine — Payments: $8,380
Dr. Evan Ownby, Md, MD
Internal Medicine — Payments: $3,602
Dr. Michael Cook, Md, MD
Internal Medicine — Payments: $3,493